Chemotherapy in Patients ≥80 with Advanced Non-small Cell Lung Cancer: Combined Results from SWOG 0027 and LUN 6

Jemal, 2006, Cancer statistics 2006, CA Cancer J Clin, 56, 106, 10.3322/canjclin.56.2.106 Hutchins, 1999, Underrepresentation of patients 65 years of age or older in cancer-treatment trials, N Engl J Med, 341, 2061, 10.1056/NEJM199912303412706 Lewis, 2003, Participation of patients 65 years of age or older in cancer clinical trials, J Clin Oncol, 21, 1383, 10.1200/JCO.2003.08.010 Kelly, 2001, Should older patients receive combination chemotherapy for advanced stage non-small cell lung cancer (NSCLC)? An analysis of Southwest Oncology trials 9509 and 9308, Proc Am Soc Clin Oncol, 20, 329s Langer, 2002, Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial, J Natl Cancer Inst, 94, 173, 10.1093/jnci/94.3.173 Lilenbaum, 2005, Single-agent versus combination chemotherapy in advanced non-small cell lung cancer. The Cancer and Leukemia Group B (study 9730), J Clin Oncol, 23, 190, 10.1200/JCO.2005.07.172 Langer, 2003, Age-specific subanalysis of ECOG 1594: fit elderly patients (70–80 yrs) with NSCLC do as well as younger patients (<70), Proc Am Soc Clin Oncol, 22, 639 Fossella, 2003, Randomized, multinational phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: the TAX 326 study group, J Clin Oncol, 22, 3016, 10.1200/JCO.2003.12.046 1999, Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group, J Natl Cancer Inst, 91, 66, 10.1093/jnci/91.1.66 Frasci, 2000, Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small cell lung cancer, J Clin Oncol, 18, 2529, 10.1200/JCO.2000.18.13.2529 Gridelli, 2003, Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial, J Natl Cancer Inst, 95, 362, 10.1093/jnci/95.5.362 Hesketh, 2006, Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027), J Thorac Oncol, 1, 537, 10.1016/S1556-0864(15)30356-7 Lilenbaum, 2007, A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer, J Thorac Oncol, 2, 306, 10.1097/01.JTO.0000263713.38826.8e Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Natl Cancer Inst, 3, 205, 10.1093/jnci/92.3.205 Pfister, 2004, American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003, J Clin Oncol, 22, 330, 10.1200/JCO.2004.09.053 Sandler, 2006, Paclitaxel—carboplatin alone or with bevacizumab for non-small-cell lung cancer, N Engl J Med, 355, 2542, 10.1056/NEJMoa061884 Schiller, 2002, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, N Engl J Med, 346, 92, 10.1056/NEJMoa011954 Kudoh, 2006, Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904), J Clin Oncol, 24, 3657, 10.1200/JCO.2006.06.1044